Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2018-05-14 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Proposed disposal for up to £1.9 million in cash
Regulatory Filings Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 0328O' and 'This information is provided by RNS') detailing a 'Proposed disposal of the Company's contract research and pharmacogenomics divisions' and includes a 'Notice of General Meeting'. The core purpose is to announce a significant corporate action (disposal) that requires shareholder approval via a General Meeting resolution (Section 190 of the Companies Act 2006). Since the document is an official regulatory announcement about a corporate event requiring shareholder vote approval, it is best classified as a general Regulatory Filing (RNS) or potentially related to the meeting itself. However, the primary function here is the announcement of the transaction and the subsequent meeting notice, which fits the broad 'Regulatory Filings' category (RNS) as it is not a specific financial report (10-K, IR, ER) or a proxy statement (PSI). Given the content is a formal announcement of a transaction requiring shareholder approval via a General Meeting, RNS is the most appropriate general regulatory classification for this type of market disclosure.
2018-05-14 English
genedrive plc to Present at the UK Investor Show
Report Publication Announcement Classification · 1% confidence The document is explicitly marked with an 'RNS Number' and contains the header 'RNS Number : 2462L' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces that the CEO and CFO will be presenting at the UK Investor Show. This is a general regulatory announcement disseminated via the Regulatory News Service (RNS) that does not fit into more specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP). Given the nature of the announcement (event participation) and the explicit RNS tagging, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2780 chars), but it is not announcing the publication of a major report, but rather an event attendance.
2018-04-18 English
Hardman & Co Research: genedrive plc (GDR): Progressing commercialisation plans
Regulatory Filings Classification · 1% confidence The document is a short announcement (3804 characters) dated 12-Apr-2018, originating from 'Hardman & Co Research' concerning 'genedrive plc'. It summarizes research findings ('Progressing commercialisation plans') and crucially contains a link to a PDF document hosted on an external site, ending with the standard disclaimer: "Dissemination of a CORPORATE NEWS, transmitted by EQS Group." This structure—a brief summary announcing the availability of detailed research/news via a link—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since 'Hardman & Co Research' notes are typically investor-focused reports, and this is the announcement of that research, RPA is the most specific fit, as it announces the publication of a report. It is not the full report itself (like 10-K or IR), nor is it a standard regulatory filing like a Director's Dealing or Earnings Release.
2018-04-12 English
Publication of Genedrive Performance Data in Gut
Regulatory Filings Classification · 1% confidence The document is identified by the presence of an 'RNS Number' (RNS Number : 3380K) and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange END'. The content announces the 'Publication of Genedrive® Hepatitis C Test Performance Data in BMJ Gut' and provides details about the study, but it is an announcement *about* the publication, not the full financial report itself. Since it is a general regulatory announcement disseminated via the RNS service and does not fit the specific categories like 10-K, ER, or IR, the most appropriate classification is the general regulatory filing category, RNS.
2018-04-10 English
Director/PDMR Shareholding
Remuneration Information Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. This structure, detailing the grant of share options to a director (Warren Berry, Operations Director) and referencing Article 19(3) of the EU Market Abuse Regulation, is characteristic of insider transaction reporting. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reports detailing personal share transactions by directors and executives, even though this specific instance is an option grant rather than a direct purchase/sale.
2018-04-04 English
genedrive signs distribution agreement for India
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory Information Service (RNS). The content describes a significant business event: signing a distribution agreement for India. This type of corporate update, which is not a formal financial report (like 10-K or IR), a management change (MANG), or a specific shareholder vote result (DVA), fits best under the general category for regulatory news releases. Since it is a general announcement released through the official channel (RNS) and doesn't fit the more specific categories like M&A (TAR) or Capital Change (CAP), the most appropriate classification is Regulatory Filings (RNS). The document length is moderate, but the content is purely an announcement of a commercial agreement, not the publication of a detailed report itself.
2018-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.